- Home
- About Us
- Team
- Portfolio Companies
- Press Room
- Contact
Konanda Pharma Partners creates companies that focus on identifying and selectively acquiring novel, commercially available therapeutic products that fulfill specific medical needs. Opportunities for our companies to acquire the rights to market, sell, manufacture and develop these products arise from several trends in the pharmaceuticals industry, such as the mergers of major pharmaceutical companies and the focus of larger companies on brands that exceed certain sales thresholds.
Even the most medically important and scientifically novel products ultimately lose marketing and promotional support from the company that first invented or marketed them. As a consequence, these products sometimes lose the attention of prescribing physicians. Konanda believes its products, based upon their safety and efficacy profiles, have the opportunity to maintain their place and grow in physicians' treatment regimes.
Konanda seeks products that provide meaningful patient and physician benefits and have the potential to grow with proper life-cycle management and brand support.
What Does "Konanda" Mean?
"Konanda" means "the place near the sand" and was the name of the American Indian village settled by the Wechquaesgek Indians on the Upper East Side of New York nearly 500 years ago. The Wechquaesgek used Konanda to describe their village because it overlooked the sandy point that at the time stretched from the mouth of the Harlem Creek into the East River. The Wechquaesgek Indians also called the island on which they lived "Manhatta." In 1626, Peter Minuit and the Dutch bought the island of Manhattan from the Indians for $24, and the Wechquaesgek tribe gradually left the island. Konanda Pharma Partners chose its name in recognition of its partners’ long-standing professional and personal ties to Manhattan and New York City.